Johnson LF: Access to antiretroviral treatment in South Africa, 2004-2011. SA J HIV Med. 2012, 13 (1): 22-27.
Google Scholar
Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K: Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002, 31 (3): 257-275.
Article
PubMed
Google Scholar
Grinspoon S, Carr A: Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005, 352 (1): 48-62.
Article
CAS
PubMed
Google Scholar
Carr A: HIV protease inhibitor-induced lipodystrophy syndrome. AIDS Rev. 1999, 1: 29-36.
Google Scholar
Carter V, Hoy J, Bailey M, Colman P, Nyulasi I, Mijch A: The prevalence of lipodystrophy in an ambulant HIV‒infected population: it all depends on the definition. HIV Med. 2001, 2 (3): 174-180.
Article
CAS
PubMed
Google Scholar
Casado JL, Iglesias V, Del Palacio M, Marín A, Perez-Elías MJ, Moreno A, Moreno S: Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy. AIDS Care. 2013, 25 (12): 1599-1603.
Article
PubMed
Google Scholar
Savès M, François R, Jacqueline C, Rozenbaum W, Ragnaud J, Perronne C, Basdevant A, Leport C, Geneviève C: Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2002, 34 (10): 1396-1405.
Article
PubMed
Google Scholar
Carr A: An objective case definition of lipodystrophy in HIV-infected adults: a case–control study. Lancet. 2003, 361 (9359): 726-735.
Article
CAS
PubMed
Google Scholar
Worm D, Kirk O, Andersen O, Vinten J, Gerstoft J, Katzenstein T, Nielsen H, Pedersen C: Clinical lipoatrophy in HIV‒1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance. HIV Med. 2002, 3 (4): 239-246.
Article
CAS
PubMed
Google Scholar
Sievers M, Walker U, Sevastianova K, Setzer B, Wågsäter D, Eriksson P, Yki-Järvinen H, Sutinen J: Gene expression and immunohistochemistry in adipose tissue of HIV type 1–infected patients with nucleoside analogue reverse-transcriptase inhibitor–associated lipoatrophy. J Infect Dis. 2009, 200 (2): 252-262.
Article
CAS
PubMed
Google Scholar
Menezes C, Maskew M, Sanne I, Crowther N, Raal F: A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. BMC Infect Dis. 2011, 11 (1): 244-
Article
PubMed Central
CAS
PubMed
Google Scholar
McComsey GA, Kitch D, Sax PE, Tebas P, Tierney C, Jahed NC, Myers L, Melbourne K, Ha B, Daar ES: Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s. Clin Infect Dis. 2011, 53 (2): 185-196.
Article
PubMed Central
CAS
PubMed
Google Scholar
Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW: Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009, 23 (9): 1109-
Article
PubMed Central
CAS
PubMed
Google Scholar
Valantin M, Lanoy E, Bentata M, Kalmykova O, Boutekadjirt A, Allavena C, Rozenbaum W, Peytavin G, Amellal B, Calvez V: Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor‒sparing therapy in patients with lipoatrophy: results from the 96‒week randomized ANRS 108 NoNuke Trial. HIV Med. 2008, 9 (8): 625-635.
Article
CAS
PubMed
Google Scholar
Asha HS, Seshadri MS, Paul TV, Abraham OC, Rupali P, Thomas N: Human immunodeficiency virus-associated lipodystrophy: an objective definition based on dual-energy x-ray absorptiometry-derived regional fat ratios in a South Asian population. Endocr Pract. 2012, 18 (2): 158-169.
Article
PubMed
Google Scholar
Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P: Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005, 8 (3): 287-292.
Article
CAS
PubMed
Google Scholar
Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL: Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy. J Clin Densitom. 2010, 13 (2): 197-203.
Article
PubMed
Google Scholar
Goedecke JH, Levitt NS, Lambert EV, Utzschneider KM, Faulenbach MV, Dave JA, West S, Victor H, Evans J, Olsson T: Differential effects of abdominal adipose tissue distribution on insulin sensitivity in black and white South African women. Obesity. 2009, 17 (8): 1506-1512.
Article
PubMed
Google Scholar
Kanaley J, Giannopoulou I, Tillapaugh-Fay G, Nappi J, Ploutz-Snyder L: Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metab Clin Exp. 2003, 52 (2): 186-191.
Article
CAS
PubMed
Google Scholar
Carroll JF, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Bae S, Cardarelli R: Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity. 2008, 16 (3): 600-607.
Article
PubMed
Google Scholar
De Waal R, Cohen K, Maartens G: Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS One. 2013, 8 (5): e63623-
Article
PubMed Central
CAS
PubMed
Google Scholar
Feleke Y, Fekade D, Mezegebu Y: Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients. Ethiop Med J. 2012, 50 (3): 221-230.
PubMed
Google Scholar
World Health Organization : Global update on HIV treatment 2013: results, impact and opportunities. [http://www.who.int/hiv/pub/progressreports/update2013/en/], []
Google Scholar
Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011, 11 (1): 246-
Article
PubMed Central
PubMed
Google Scholar
Masiá M, Padilla S, García N, Jarrin I, Bernal E, López N, Hernández I, Gutiérrez F: Endothelial function is impaired in HIV-infected patients with lipodystrophy. Antivir Ther. 2010, 15 (1): 101-110.
Article
PubMed
Google Scholar
Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, Currier JS: Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011, 23 (8): 929-938.
Article
PubMed Central
PubMed
Google Scholar
Guaraldi G, Murri R, Orlando G, Giovanardi C, Squillace N, Vandelli M, Beghetto B, Nardini G, De Paola M, Esposito R: Severity of lipodystrophy is associated with decreased health-related quality of life. AIDS Patient Care STDS. 2008, 22 (7): 577-585.
Article
PubMed Central
PubMed
Google Scholar
Huang JS, Harrity S, Lee D, Becerra K, Santos R, Mathews WC: Body image in women with HIV: a cross-sectional evaluation. AIDS Res Ther. 2006, 3 (17): 1-7.
CAS
Google Scholar
Tungsiripat M, O’Riordan MA, Storer N, Harrill D, Ganz J, Libutti D, Gerschenson M, McComsey GA: Subjective clinical lipoatrophy assessment correlates with DEXA-measured limb fat. HIV Clin Trials. 2009, 10 (5): 314-319.
Article
PubMed
Google Scholar
Van Oosterhout JJ, Mallewa J, Kaunda S, Chagoma N, Njalale Y, Kampira E, Mukaka M, Heyderman RS: Stavudine toxicity in adult longer-term ART patients in Blantyre. Malawi PLos One. 2012, 7 (7): e42029-
Article
CAS
PubMed
Google Scholar
Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG: Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. J Acquir Immune Defic Syndr. 2009, 51 (1): 37-46.
Article
PubMed Central
CAS
PubMed
Google Scholar
Thompson V, Medard B, Taseera K, Chakera AJ, Andia I, Emenyonu N, Hunt PW, Martin J, Scherzer R, Weiser SD: Regional anthropometry changes in antiretroviral-naive persons initiating a Zidovudine-containing regimen in Mbarara. Uganda AIDS Res Hum Retroviruses. 2011, 27 (7): 785-791.
Article
CAS
PubMed
Google Scholar
George JA, Venter WD, Van Deventer HE, Crowther NJ: A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Res Hum Retroviruses. 2009, 25 (8): 771-781.
Article
CAS
PubMed
Google Scholar
Goedecke JH, Micklesfield LK, Levitt NS, Lambert EV, West S, Maartens G, Dave JA: Effect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women. AIDS Res Hum Retroviruses. 2013, 29 (3): 557-563.
Article
CAS
PubMed
Google Scholar
Department of Health: The South African antiretroviral treatment guidelines. [http://www.auruminstitute.org/phocadownload/guidelines-short.pdf], []
Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ, Rhodes PH, Wood KC, Holmberg SD: Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001, 15 (11): 1389-1398.
Article
CAS
PubMed
Google Scholar
Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS: Effect of nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr. 2011, 57 (4): 284-289.
Article
CAS
PubMed
Google Scholar